ArticlebioRxiv : the preprint server for biology2020

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2

Nir Drayman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.